AbCellera Biologics ABCL
NASDAQ ABCL
$11.57 -0.36 (-2.98%)
As of: Oct 20, 2026 · 11:47 AM EDT

AbCellera Biologics (ABCL) Prepaid Assets (2020 - 2022)

Updated

AbCellera Biologics' Prepaid Assets was $9.06 million in Q4 2022, up 71.2% from $5.29 million a year earlier.

Analysis

AbCellera Biologics (ABCL) Prepaid Assets (2020 - 2022) Analysis & Trends

From Q4 2020 onward, AbCellera Biologics has reported Prepaid Assets for 5 quarters.

  • In earlier years, Prepaid Assets was $5.29 million in FY2021 (+30.0%) and $4.07 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,161.07 Bn 1,129.66 Bn 19.71 Bn
2 Johnson & Johnson 624.64 Bn 543.17 Bn 17.26 Bn
3 AbbVie 511.75 Bn 484.87 Bn 12.70 Bn
4 Merck 366.33 Bn 320.70 Bn 12.21 Bn
5 Novartis Ag 297.54 Bn 261.53 Bn 11.24 Bn
6 Astrazeneca 261.44 Bn 235.12 Bn 12.86 Bn
7 Amgen 235.03 Bn 190.43 Bn 7.24 Bn
8 Gilead Sciences 194.15 Bn 168.35 Bn 6.22 Bn
9 Pfizer 171.65 Bn 118.30 Bn 10.94 Bn
10 AbCellera Biologics 3.53 Bn 2.99 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 9.06 Mn
Dec 31, 2021 5.29 Mn
Jun 30, 2021 4.92 Mn
Mar 31, 2021 4.29 Mn
Dec 31, 2020 4.07 Mn
API Access

AbCellera Biologics Prepaid Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=prepaid-assets&ticker=ABCL&period=max&api_key=YOUR_API_KEY